CS

Candriam SCA Portfolio holdings

AUM $20.1B
1-Year Est. Return 37.07%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+37.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
736
New
Increased
Reduced
Closed

Top Buys

1
+$85M
2
+$53.8M
3
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

1
+$80.5M
2
+$54.5M
3
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
626
$332K ﹤0.01%
12,530
-552
627
$330K ﹤0.01%
+16,274
628
$327K ﹤0.01%
7,300
629
$327K ﹤0.01%
31,619
630
$323K ﹤0.01%
+6,773
631
$308K ﹤0.01%
9,810
-2,879
632
– –
-101,482
633
$304K ﹤0.01%
7,000
-707,500
634
$301K ﹤0.01%
2,654
-152
635
$290K ﹤0.01%
3,918
-998
636
$282K ﹤0.01%
5,797
-2,994
637
$261K ﹤0.01%
1,821
-1,704
638
$252K ﹤0.01%
6,730
-2,962
639
$251K ﹤0.01%
3,135
-1,905
640
$242K ﹤0.01%
11,858
-32,777
641
$225K ﹤0.01%
+2,121
642
$220K ﹤0.01%
28,764
643
$217K ﹤0.01%
2,074
-167
644
$215K ﹤0.01%
+7,220
645
$104K ﹤0.01%
53,054
646
$56.5K ﹤0.01%
+10,000
647
$48.2K ﹤0.01%
+11,000
648
– –
-18,422
649
– –
-233,000
650
– –
-348,434
24 25
26
27 28